These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20724264)

  • 41. Conserved domains and lack of evidence for polyglutamine length polymorphism in the chicken homolog of the Machado-Joseph disease gene product ataxin-3.
    Linhartová I; Repitz M; Dráber P; Nemec M; Wiche G; Propst F
    Biochim Biophys Acta; 1999 Feb; 1444(2):299-305. PubMed ID: 10023088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Detection of the CAG trinucleotide repeats of MJD1 gene by recombinant DNA technology].
    Zhang S; Wang JL; Xu Q; Li XH; Lei LF; Jiang H; Shen L; Yan XX; Pan Q; Xia K; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):406-9. PubMed ID: 20017304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gender equality in Machado-Joseph disease.
    Dürr A; Stevanin G; Cancel G; Abbas N; Chneiweiss H; Agid Y; Feingold J; Brice A
    Nat Genet; 1995 Oct; 11(2):118-9. PubMed ID: 7550335
    [No Abstract]   [Full Text] [Related]  

  • 46. Cambodian founder effect for spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Jayadev S; Michelson S; Lipe H; Bird T
    J Neurol Sci; 2006 Dec; 250(1-2):110-3. PubMed ID: 17027034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
    Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
    Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
    Matos CA; de Macedo-Ribeiro S; Carvalho AL
    Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and functional dissection of localization signals within ataxin-3.
    Antony PM; Mäntele S; Mollenkopf P; Boy J; Kehlenbach RH; Riess O; Schmidt T
    Neurobiol Dis; 2009 Nov; 36(2):280-92. PubMed ID: 19660550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin type A for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease).
    Freeman W; Wszolek Z
    Mov Disord; 2005 May; 20(5):644. PubMed ID: 15747361
    [No Abstract]   [Full Text] [Related]  

  • 52. Teaching NeuroImages: Retinopathy in spinocerebellar ataxia type 3.
    Nascimento FA; Ferreira MG; Shiokawa N; Sato MT; Teive HAG
    Neurology; 2020 May; 94(21):e2283-e2284. PubMed ID: 32332129
    [No Abstract]   [Full Text] [Related]  

  • 53. Machado-Joseph disease in three Scandinavian families.
    Løkkegaard T; Nielsen JE; Hasholt L; Fenger K; Werdelin L; Tranebjaerg L; Lauritzen M; Colding-Jørgensen E; Grønbech-Jensen M; Henriksen OA; Sørensen SA
    J Neurol Sci; 1998 Apr; 156(2):152-7. PubMed ID: 9588850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improvement in the molecular diagnosis of Machado-Joseph disease.
    Maciel P; Costa MC; Ferro A; Rousseau M; Santos CS; Gaspar C; Barros J; Rouleau GA; Coutinho P; Sequeiros J
    Arch Neurol; 2001 Nov; 58(11):1821-7. PubMed ID: 11708990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease.
    Yu YC; Kuo CL; Cheng WL; Liu CS; Hsieh M
    J Neurosci Res; 2009 Jun; 87(8):1884-91. PubMed ID: 19185026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
    Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
    Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
    Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
    J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased transcript diversity: novel splicing variants of Machado-Joseph disease gene (ATXN3).
    Bettencourt C; Santos C; Montiel R; Costa Mdo C; Cruz-Morales P; Santos LR; Simões N; Kay T; Vasconcelos J; Maciel P; Lima M
    Neurogenetics; 2010 May; 11(2):193-202. PubMed ID: 19714377
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Machado-Joseph disease gene products carrying different carboxyl termini.
    Goto J; Watanabe M; Ichikawa Y; Yee SB; Ihara N; Endo K; Igarashi S; Takiyama Y; Gaspar C; Maciel P; Tsuji S; Rouleau GA; Kanazawa I
    Neurosci Res; 1997 Aug; 28(4):373-7. PubMed ID: 9274833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.